BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8671903)

  • 1. Survey of permanent central venous catheters for haemodialysis in the UK.
    Kumwenda MJ; Wright FK; Haybittle KJ
    Nephrol Dial Transplant; 1996 May; 11(5):830-2. PubMed ID: 8671903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis catheter exit site care.
    Astle CM
    Contrib Nephrol; 2007; 154():84-96. PubMed ID: 17099303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septicemia in long-term jugular hemodialysis catheters; eradicating infection by changing the catheter over a guidewire.
    Carlisle EJ; Blake P; McCarthy F; Vas S; Uldall R
    Int J Artif Organs; 1991 Mar; 14(3):150-3. PubMed ID: 2045189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of haemodialysis with cuffed central-vein catheters.
    Atherikul K; Schwab SJ; Conlon PJ
    Nephrol Dial Transplant; 1998 Mar; 13(3):745-9. PubMed ID: 9550658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective flow performances and dialysis doses delivered with permanent catheters: a 24-month comparative study of permanent catheters versus arterio-venous vascular accesses.
    Canaud B; Leray-Moragues H; Kerkeni N; Bosc JY; Martin K
    Nephrol Dial Transplant; 2002 Jul; 17(7):1286-92. PubMed ID: 12105254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China.
    Wang K; Wang P; Liang X; Lu X; Liu Z
    BMJ Open; 2015 Nov; 5(11):e007136. PubMed ID: 26589425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors and complications affecting catheter and technique survival with permanent single-lumen dialysis catheters.
    De Meester J; Vanholder R; De Roose J; Ringoir S
    Nephrol Dial Transplant; 1994; 9(6):678-83. PubMed ID: 7970096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Temporary and permanent central venous catheters for hemodialysis].
    Premužić V; Tomašević B; Eržen G; Makar K; Brunetta-Gavranić B; Francetić I; Bašić-Jukić N; Kes P; Jelaković B
    Acta Med Croatica; 2014 Apr; 68(2):167-74. PubMed ID: 26012155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of central venous catheter as permanent hemodialysis access: 84-month follow-Up in lucania.
    Di Iorio B; Lopez T; Procida M; Marino P; Valente V; Iannuzziello F; Bombini A; Bellizzi V; Terracciano V; Bagnato C; Casino F; Gaudiano V; Mostacci D; Santarsia G; Biscione R; Caputo A; Ferlan G; Lauria MA; Marinaro G; Molinari R; Sanicandro D; Lotito MA; Plastino G; Carretta P
    Blood Purif; 2001; 19(1):39-43. PubMed ID: 11114576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do AshSplit haemodialysis catheters provide better flow rates in the long term?
    Keeling AN; O'Dwyer H; Lyon S; O'Kelly P; McGrath FP; Conlon PJ; Lee MJ
    Ren Fail; 2007; 29(6):721-9. PubMed ID: 17763168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters.
    McCann M; Moore ZE
    Cochrane Database Syst Rev; 2010 Jan; (1):CD006894. PubMed ID: 20091610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis.
    Skofic N; Buturović-Ponikvar J; Kovac J; Premru V; Knap B; Marn Pernat A; Kersnic B; Gubensek J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):327-33. PubMed ID: 19695069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious risk associated with arterial catheters compared with central venous catheters.
    Lucet JC; Bouadma L; Zahar JR; Schwebel C; Geffroy A; Pease S; Herault MC; Haouache H; Adrie C; Thuong M; Français A; Garrouste-Orgeas M; Timsit JF
    Crit Care Med; 2010 Apr; 38(4):1030-5. PubMed ID: 20154601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IV 3000 dressing on Permcath exit sites.
    Latta C; Grant C
    EDTNA ERCA J; 1996; 22(1):7-8. PubMed ID: 10723301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining an optimum haemocatheter exit site.
    Wittich E
    EDTNA ERCA J; 2001; 27(2):81-2. PubMed ID: 11868754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inserting tunnelled hemodialysis catheters using elective guidewire exchange from nontunnelled catheters: is there a greater risk of infection when compared with new-site replacement?
    Casey J; Davies J; Balshaw-Greer A; Taylor N; Crowe AV; McClelland P
    Hemodial Int; 2008 Jan; 12(1):52-4. PubMed ID: 18271841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a quality improvement project.
    Apata IW; Hanfelt J; Bailey JL; Niyyar VD
    J Vasc Access; 2017 Mar; 18(2):103-108. PubMed ID: 28165583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular access management III: central venous catheters.
    McCann M; Einarsdottir H; Van Waeleghem JP; Murphy F; Sedgewick J
    J Ren Care; 2010 Mar; 36(1):25-33. PubMed ID: 20214706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.